Skip to content
  • Blog (Home)
    • Transfusion Medicine
    • Blood Bank IT
    • COVID-19 Plasma CCP
    • Plasma Fractionation
  • About me
  • Work with me
  • Contact me
Search
Close

Dr. Zeyd Merenkov

Transfusion Medicine, Blood Bank IT, Pathogen Inactivation, Plasma Fractionation, COVID-19 Convalescent Plasma Production

Donor

Abnormal Marker Testing Algorithm: Revised December 2020

16th Jan 20219th Jan 2021 drzeyd

Share this:

  • LinkedIn
  • Twitter
  • Facebook

Like this:

Like Loading...

Related

Donor Marker Testing

Post navigation

Previous Post
COVID-19 Convalescent Plasma CCP Donor Questionnaire and Collection
Next Post
COVID-19 Impact on Blood Supplies in the Middle East

Follow Me

  • LinkedIn
  • RSS Feed

Categories

  • Blood Bank IT (269)
  • COVID-19 (48)
  • Plasma Fractionation (6)
  • Transfusion Medicine (513)
    • Administration (73)
    • Apheresis (81)
    • Donor (262)
    • Patient (329)
    • Teaching (235)
    • Transplantation (20)
  • Uncategorized (2)

Tags

Autologous Donation COVID-19 Plasma Donor Apheresis Donor Collection Donor Counseling Donor Immunohematology Donor Marker Testing Donor Processing General Laboratory Software Immunohematology Medinfo Hematos IIG Mirasol Plasma Fractionation Processes and Software Building Quality Assurance Reveos Therapeutic Apheresis

Archives

  • Oct 2021 (22)
  • Sep 2021 (30)
  • Aug 2021 (31)
  • Jul 2021 (31)
  • Jun 2021 (30)
  • May 2021 (33)
  • Apr 2021 (30)
  • Mar 2021 (31)
  • Feb 2021 (28)
  • Jan 2021 (32)
  • Dec 2020 (31)
  • Nov 2020 (30)
  • Oct 2020 (31)
  • Sep 2020 (31)
  • Aug 2020 (34)
  • Jul 2020 (35)
  • Jun 2020 (28)
  • Apr 2020 (1)
Blog at WordPress.com.
Back to top
 

Loading Comments...
 

    %d bloggers like this: